JP4690928B2 - Allergen detection method by immunochromatography - Google Patents
Allergen detection method by immunochromatography Download PDFInfo
- Publication number
- JP4690928B2 JP4690928B2 JP2006103678A JP2006103678A JP4690928B2 JP 4690928 B2 JP4690928 B2 JP 4690928B2 JP 2006103678 A JP2006103678 A JP 2006103678A JP 2006103678 A JP2006103678 A JP 2006103678A JP 4690928 B2 JP4690928 B2 JP 4690928B2
- Authority
- JP
- Japan
- Prior art keywords
- allergen
- denatured
- allergens
- immunochromatography
- fetal bovine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000013566 allergen Substances 0.000 title claims description 97
- 238000003317 immunochromatography Methods 0.000 title claims description 33
- 238000001514 detection method Methods 0.000 title claims description 27
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 68
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 56
- 239000012091 fetal bovine serum Substances 0.000 claims description 56
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 34
- 235000018102 proteins Nutrition 0.000 claims description 29
- 102000004169 proteins and genes Human genes 0.000 claims description 29
- 108090000623 proteins and genes Proteins 0.000 claims description 29
- 235000013305 food Nutrition 0.000 claims description 26
- 238000005259 measurement Methods 0.000 claims description 18
- 238000012360 testing method Methods 0.000 claims description 14
- 238000011161 development Methods 0.000 claims description 12
- 108010000912 Egg Proteins Proteins 0.000 claims description 11
- 102000002322 Egg Proteins Human genes 0.000 claims description 11
- 229940092253 ovalbumin Drugs 0.000 claims description 11
- 241000219051 Fagopyrum Species 0.000 claims description 10
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 10
- 241000209140 Triticum Species 0.000 claims description 9
- 235000021307 Triticum Nutrition 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 9
- 108010061711 Gliadin Proteins 0.000 claims description 8
- 235000013336 milk Nutrition 0.000 claims description 7
- 239000008267 milk Substances 0.000 claims description 7
- 210000004080 milk Anatomy 0.000 claims description 7
- 244000105624 Arachis hypogaea Species 0.000 claims description 6
- 108010058846 Ovalbumin Proteins 0.000 claims description 6
- 108010064983 Ovomucin Proteins 0.000 claims description 6
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 5
- 102000009366 Alpha-s1 casein Human genes 0.000 claims description 5
- 108050000244 Alpha-s1 casein Proteins 0.000 claims description 5
- 102000008192 Lactoglobulins Human genes 0.000 claims description 5
- 108010060630 Lactoglobulins Proteins 0.000 claims description 5
- 239000005862 Whey Substances 0.000 claims description 5
- 102000007544 Whey Proteins Human genes 0.000 claims description 5
- 108010046377 Whey Proteins Proteins 0.000 claims description 5
- 235000014103 egg white Nutrition 0.000 claims description 5
- 210000000969 egg white Anatomy 0.000 claims description 5
- 235000020232 peanut Nutrition 0.000 claims description 5
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 4
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 4
- 235000018262 Arachis monticola Nutrition 0.000 claims description 4
- 239000000243 solution Substances 0.000 description 66
- 239000000523 sample Substances 0.000 description 47
- 238000006243 chemical reaction Methods 0.000 description 34
- 210000004408 hybridoma Anatomy 0.000 description 22
- 239000012528 membrane Substances 0.000 description 13
- 206010029719 Nonspecific reaction Diseases 0.000 description 12
- 239000011491 glass wool Substances 0.000 description 10
- 238000000605 extraction Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000012085 test solution Substances 0.000 description 8
- 239000003398 denaturant Substances 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 235000013622 meat product Nutrition 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000008055 phosphate buffer solution Substances 0.000 description 7
- 239000007853 buffer solution Substances 0.000 description 6
- 239000000020 Nitrocellulose Substances 0.000 description 5
- 239000002250 absorbent Substances 0.000 description 5
- 230000002745 absorbent Effects 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 5
- 238000003018 immunoassay Methods 0.000 description 5
- 238000002372 labelling Methods 0.000 description 5
- 229920001220 nitrocellulos Polymers 0.000 description 5
- 241000287523 Ara Species 0.000 description 4
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 3
- 102000014171 Milk Proteins Human genes 0.000 description 3
- 108010011756 Milk Proteins Proteins 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 230000008105 immune reaction Effects 0.000 description 3
- 235000021239 milk protein Nutrition 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000416536 Euproctis pseudoconspersa Species 0.000 description 2
- 208000004262 Food Hypersensitivity Diseases 0.000 description 2
- 101000951145 Homo sapiens Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial Proteins 0.000 description 2
- 101000654245 Homo sapiens Succinate dehydrogenase assembly factor 2, mitochondrial Proteins 0.000 description 2
- 102100038014 Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial Human genes 0.000 description 2
- 102100031715 Succinate dehydrogenase assembly factor 2, mitochondrial Human genes 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 235000020932 food allergy Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000013076 target substance Substances 0.000 description 2
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000013568 food allergen Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Description
本発明は、各種アレルゲンを含む食品等の被検試料から、ＳＤＳと２−メルカプトエタノールを用いて、各アレルゲンを抽出し、各アレルゲンが変性／未変性のいかなる状態にあってもＳＤＳと２−メルカプトエタノールで効率よく抽出し、さらに、ＳＤＳと２−メルカプトエタノールにより抗体に結合した金コロイドの崩壊に伴う非特異反応を抑え、迅速に検出することのできるイムノクロマト法によるアレルゲンの検出方法やそれに使用することができるイムノクロマト用アレルゲンの検出キットに関する。 In the present invention, each allergen is extracted from a test sample such as a food containing various allergens using SDS and 2-mercaptoethanol, and the SDS and the 2- Allergen detection method by immunochromatography that can be extracted efficiently with mercaptoethanol and non-specific reaction associated with collapsing of gold colloid bound to antibody with SDS and 2-mercaptoethanol can be detected quickly and used for it The present invention relates to a detection kit for an immunochromatographic allergen.
自然環境の減少、車や工場などからの排気ガス、住宅事情等、或いは食べ物の変化など様々な因子により、現在では、３人に１人が何らかのアレルギー疾患をもつといわれている。特に、食物アレルギーは、食品中に含まれるアレルギー誘発物質（以下、食物アレルゲンという）の摂取が引き起こす有害な免疫反応であり、皮膚炎、喘息、消化管障害、アナフィラキシーショック等を引き起こし、このような食物アレルギーの患者が増加していることから、医学上及び食品産業上、深刻な問題を生じている。これらの危害は死に至らせることがあり、未然に処置を施す必要がある。そのためには、表示を通じて消費者へ情報提供の必要性も高まっており、ＦＡＯ／ＷＨＯ合同食品規格委員会は、アレルギー物質として知られている８種の原材料を含む食品にあっては、それを含む旨の表示について合意し、加盟国で各国の制度に適した表示方法を検討することとした（１９９９年６月）。日本では過去の健康危害などの程度、頻度を考慮して重篤なアレルギー症状を起した実績のある２４品目の食品について、その表示方法が定められた（２００２年４月より施行）。アレルギーを引き起こす食品としては、卵類、牛乳類、肉類、魚類、甲殻類及び軟体動物類、穀類、豆類及びナッツ類、果実類、野菜類、ビール酵母若しくはゼラチンなどが知られている。 Due to various factors such as a decrease in the natural environment, exhaust gas from cars and factories, housing conditions, and changes in food, one in three people is now said to have some allergic disease. In particular, food allergies are harmful immune reactions caused by the intake of allergens (hereinafter referred to as food allergens) contained in foods, causing dermatitis, asthma, gastrointestinal disorders, anaphylactic shock, etc. The increasing number of patients with food allergies has caused serious problems in medicine and the food industry. These harms can be fatal and require action. To that end, the need to provide information to consumers through the labeling is increasing, and the FAO / WHO Joint Food Standards Committee has confirmed that for foods containing eight kinds of raw materials known as allergic substances. Agreed to indicate that it is included, and decided to consider a labeling method suitable for each country's system in the member countries (June 1999). In Japan, a labeling method was established for 24 food items that had a history of causing severe allergic symptoms in consideration of the degree and frequency of past health hazards (effective from April 2002). As foods causing allergies, eggs, milk, meat, fish, crustaceans and mollusks, cereals, beans and nuts, fruits, vegetables, brewer's yeast, gelatin and the like are known.
上記のアレルゲンを迅速で簡易に検出するため、抗原−抗体による特異的反応を利用して特定の抗原または抗体よりなる被検出物質を検出する免疫測定法としては、試料中の被検出物質を、微粒子に感作させた抗体または抗原と免疫反応により結合させ、結合によって生じる微粒子の凝集状態を測定する凝集法が簡便な免疫測定法であり、特に目視判定が可能である点で一般的に用いられている方法である。 In order to detect the above-mentioned allergen quickly and easily, as an immunoassay for detecting a target substance comprising a specific antigen or antibody using a specific reaction by an antigen-antibody, the target substance in a sample is An agglutination method that binds an antibody or antigen sensitized to microparticles by an immune reaction and measures the aggregation state of the microparticles resulting from the binding is a simple immunoassay method, and is generally used because it can be visually judged. It is the method that has been.
また、試料中の被検出物質に、放射性同位元素、酵素または蛍光物質からなる標識物質により標識した抗体または抗原を免疫反応により結合させ、この結合した標識物質を測定する放射免疫測定法、酵素免疫測定法あるいは蛍光免疫測定法も採用されている。これらの免疫測定法では、競合型反応、サンドイッチ型反応が広く使われている。これらのうち、いわゆるサンドイッチ型反応の測定法として、イムノクロマトグラフィー法が知られており（例えば、特許文献１参照。）、抗原抗体反応に起因する高い特異性に加え、簡易、迅速を特徴とする種々のアレルゲン検出キットが販売されている。 In addition, a radioimmunoassay method or enzyme immunity method in which an antibody or antigen labeled with a labeling substance composed of a radioisotope, an enzyme or a fluorescent substance is bound to an analyte in a sample by an immune reaction, and the bound labeling substance is measured. Measurement methods or fluorescence immunoassays are also employed. In these immunoassays, competitive reaction and sandwich reaction are widely used. Among these, as a so-called sandwich type reaction measurement method, an immunochromatography method is known (see, for example, Patent Document 1), which is characterized by simplicity and speed in addition to high specificity resulting from an antigen-antibody reaction. Various allergen detection kits are on the market.
かかるイムノクロマトグラフィー法に適用される試料としては、生体試料や食品からの抽出物などあるが、試料の種類によっては、検体が存在しないにもかかわらず捕捉部位で淡い呈色を示す所謂非特異反応を生じることがあり、検査における確度の低下をもたらすことがあった。そこで、緩衝液中に、ホスホリルコリン基を有する重合体を、０.００５〜０.３ｗ／ｖ％の濃度で含有し、該重合体の数平均分子量は４０，０００以上であることを特徴とする、測定時の非特異的凝集および非特異反応を防止し、以って、高い確度で測定を可能とする展開溶媒（例えば、特許文献２参照。）が提案されている。 Samples applied to such immunochromatography include biological samples and extracts from foods, but depending on the type of sample, a so-called non-specific reaction that shows a light color at the capture site despite the absence of the specimen. May cause a decrease in accuracy in inspection. Therefore, the buffer contains a polymer having a phosphorylcholine group at a concentration of 0.005 to 0.3 w / v%, and the number average molecular weight of the polymer is 40,000 or more. There has been proposed a developing solvent (see, for example, Patent Document 2) that prevents nonspecific aggregation and nonspecific reaction during measurement, and thus enables measurement with high accuracy.
また、上記免疫測定法においては、タンパク質に加熱や加圧などによって変性等が生じた場合、測定結果が低くなったり、測定できないケースが認められていた。そこで、サンドイッチＥＬＩＳＡ法では、加熱した被検試料から各アレルゲンを十分に抽出するために、変性剤及び還元剤を用いた抽出溶液を用いて抽出する方法が公定法として採用されている。しかしながら、これらをイムノクロマトグラフィー法に適応した場合、多くの非特異反応が見られるために正確な検査ができず、変性タンパク質を測定する際に問題となっていた。 Further, in the above immunoassay method, when the protein is denatured by heating or pressurization, the measurement result is sometimes lowered or cannot be measured. Therefore, in the sandwich ELISA method, an extraction method using an extraction solution using a denaturant and a reducing agent is adopted as an official method in order to sufficiently extract each allergen from a heated test sample. However, when these are applied to the immunochromatography method, many non-specific reactions are observed, so that an accurate test cannot be performed, which causes a problem when measuring denatured proteins.
本発明の課題は、各アレルゲンを含む食品等の被検試料から、ＳＤＳと２−メルカプトエタノールを用いて、各アレルゲンを抽出し、各アレルゲンが変性／未変性のいかなる状態にあってもＳＤＳと２−メルカプトエタノールで効率よく抽出し、さらに、ＳＤＳと２−メルカプトエタノールにより抗体に結合した金コロイドの崩壊に伴う非特異反応を抑え、迅速かつ精度よくアレルゲンを検出することのできるイムノクロマト法によるアレルゲンの検出方法やそれに用いることができるイムノクロマト用アレルゲンの検出キットを提供することにある。 An object of the present invention is to extract each allergen from a test sample such as food containing each allergen using SDS and 2-mercaptoethanol, and to determine whether SDS is in any denatured / native state. An allergen by immunochromatography that can be efficiently extracted with 2-mercaptoethanol, further suppresses non-specific reactions associated with the collapse of colloidal gold bound to the antibody with SDS and 2-mercaptoethanol, and can detect allergens quickly and accurately. And a detection kit for an immunochromatographic allergen that can be used in the method.
本発明者らは、加熱製品の抽出に変性剤及び還元剤（ＳＤＳと２−メルカプトエタノール）を用いた場合でも、非特異反応がなく迅速で簡易に検出することのできるイムノクロマト法において、ウシ胎児血清（fetal bovine serum：ＦＢＳ）を含む展開液を用いると、前記課題を解決できることを見い出し、本発明を完成するに至った。 In the immunochromatography method in which a denaturant and a reducing agent (SDS and 2-mercaptoethanol) are used for extraction of a heated product and there is no non-specific reaction and can be detected quickly, fetal bovine fetus It has been found that the use of a developing solution containing serum (fetal bovine serum: FBS) can solve the above problems, and the present invention has been completed.
すなわち本発明は、（１）変性及び未変性のアレルゲンに対するモノクローナル抗体に金コロイドを結合した金コロイド標識抗体と、前記金コロイド標識抗体と異なるエピトープを認識する変性及び未変性のアレルゲンに対するモノクローナル抗体が所定の位置に固定された展開支持体と、アレルゲンを含む食品等の被検試料から、ＳＤＳと２−メルカプトエタノールを用いて抽出した変性及び未変性のアレルゲンの測定サンプルを含む展開液を用い、展開支持体に展開させた後、金コロイドの集積の有無により、アレルゲンを検出するイムノクロマト法において、ウシ胎児血清（ＦＢＳ）が少なくとも１０重量％含まれている展開液を用いることを特徴とするイムノクロマト法によるアレルゲンの検出方法や、（２）ウシ胎児血清（ＦＢＳ）が少なくとも３０重量％含まれている展開液を用いることを特徴とする前記（１）記載のイムノクロマト法によるアレルゲンの検出方法や、（３）ウシ胎児血清（ＦＢＳ）が少なくとも５０重量％含まれている展開液を用いることを特徴とする前記（２）記載のイムノクロマト法によるアレルゲンの検出方法や、（４）変性及び未変性のアレルゲンに対するモノクローナル抗体が、乳アレルゲンの主要成分としてのαｓ１カゼイン、ホエーアレルゲンの主要成分であるβラクトグロブリン、卵白アレルゲンとしてのオボアルブミンとオボムコイド、小麦アレルゲンの主要成分としてのグリアジン、そばの主要タンパク質である分子量２４ｋＤａと７６ｋＤａのタンパク質、落花生の主要タンパク質であるＡｒａｈ１から選ばれる変性及び未変性のアレルゲンを特異的に認識する２種類のモノクローナル抗体であることを特徴とする前記（１）〜（３）のいずれか記載のイムノクロマト法によるアレルゲンの検出方法に関する。 That is, the present invention includes (1) a colloidal gold-labeled antibody in which colloidal gold is bound to a monoclonal antibody against a denatured and native allergen, and a monoclonal antibody against a denatured and native allergen that recognizes an epitope different from the colloidal gold labeled antibody. Using a developing solution containing a measurement sample of denatured and undenatured allergens extracted using SDS and 2-mercaptoethanol from a test sample such as a food support containing allergens and a development support fixed in place, In an immunochromatography method for detecting allergens based on the presence or absence of accumulation of colloidal gold after being developed on a development support, an immunochromatography using a development solution containing at least 10% by weight of fetal bovine serum (FBS) (2) Fetal bovine serum (FBS) A developing solution containing at least 30% by weight of an allergen by the immunochromatography method according to the above (1), or (3) containing at least 50% by weight of fetal bovine serum (FBS) And (4) a method for detecting allergens by immunochromatography as described in (2) above, and (4) monoclonal antibodies against denatured and undenatured allergens, αs1 casein and whey as main components of milk allergens. Selected from β-lactoglobulin, the main component of allergen, ovalbumin and ovomucoid as egg white allergen, gliadin as the main component of wheat allergen, proteins with molecular weights of 24 kDa and 76 kDa as buckwheat proteins, and Arah1, the main protein of peanut Modified and unchanged The method for detecting allergen by specific above, wherein the recognizing a two monoclonal antibodies (1) - immunochromatography according to any one of (3) the allergen.
また本発明は、（５）変性及び未変性のアレルゲンに対するモノクローナル抗体に金コロイドを結合した金コロイド標識抗体を担持させた金コロイド標識抗体担持体、前記金コロイド標識抗体と異なるエピトープを認識する変性及び未変性のアレルゲンに対するモノクローナル抗体が所定の位置に固定された展開支持体と、アレルゲンを含む食品等の被検試料から、変性及び未変性のアレルゲンを抽出するためのＳＤＳと２−メルカプトエタノールを含有する緩衝液と、アレルゲンを含む食品等の被検試料から、ＳＤＳと２−メルカプトエタノールを用いて抽出した変性及び未変性のアレルゲンの測定サンプルを担持させることができるサンプル用担体と、ウシ胎児血清（ＦＢＳ）又はウシ胎児血清（ＦＢＳ）を含む展開液とを備えたことを特徴とするイムノクロマト用アレルゲンの検出キットや、（６）変性及び未変性のアレルゲンに対するモノクローナル抗体が、乳アレルゲンの主要成分としてのαｓ１カゼイン、ホエーアレルゲンの主要成分であるβラクトグロブリン、卵白アレルゲンとしてのオボアルブミンとオボムコイド、小麦アレルゲンの主要成分としてのグリアジン、そばの主要タンパク質である分子量２４ｋＤａと７６ｋＤａのタンパク質、落花生の主要タンパク質であるＡｒａｈ１から選ばれる変性及び未変性のアレルゲンを特異的に認識する２種類のモノクローナル抗体であることを特徴とする前記（５）記載のイムノクロマト用アレルゲンの検出キットに関する。 Further, the present invention provides (5) a colloidal gold-labeled antibody carrying a colloidal gold-conjugated antibody in which a colloidal gold antibody is bound to a monoclonal antibody against a denatured and undenatured allergen, and a denaturation that recognizes an epitope different from the colloidal gold-labeled antibody. And a development support on which a monoclonal antibody against a native allergen is fixed at a predetermined position, and SDS and 2-mercaptoethanol for extracting denatured and native allergen from a test sample such as food containing the allergen. A sample carrier capable of carrying a measurement sample of denatured and undenatured allergens extracted from a test sample such as a food containing allergen and buffer using SDS and 2-mercaptoethanol, and a fetal bovine A developing solution containing serum (FBS) or fetal bovine serum (FBS) Immunochromatographic allergen detection kit, and (6) monoclonal antibodies against denatured and undenatured allergens are αs1 casein as the main component of milk allergen, β-lactoglobulin as the main component of whey allergen, and egg white allergen It specifically recognizes denatured and native allergens selected from ovalbumin and ovomucoid, gliadin as a major component of wheat allergen, buckwheat major proteins of molecular weight 24 kDa and 76 kDa, and peanut major protein Arah1 2 The present invention relates to the immunochromatographic allergen detection kit according to (5), which is a kind of monoclonal antibody.
本発明のイムノクロマト法によるアレルゲンの検出方法によると、加熱製品の抽出に変性剤及び還元剤（ＳＤＳと２−メルカプトエタノール）を用いた場合でも、ＳＤＳと２−メルカプトエタノールにより抗体に結合した金コロイドの崩壊に伴う非特異反応を抑え、迅速かつ精度よく各種アレルゲンを検出することができる。 According to the allergen detection method by the immunochromatography method of the present invention, even when a denaturant and a reducing agent (SDS and 2-mercaptoethanol) are used for extraction of a heated product, colloidal gold bound to an antibody by SDS and 2-mercaptoethanol. It is possible to suppress non-specific reactions associated with the decay of and to detect various allergens quickly and accurately.
本発明のイムノクロマト法によるアレルゲンの検出方法としては、変性及び未変性のアレルゲンに対するモノクローナル抗体に金コロイドを結合した金コロイド標識抗体と、前記金コロイド標識抗体と異なるエピトープを認識する変性及び未変性のアレルゲンに対するモノクローナル抗体が所定の位置に固定された展開支持体と、アレルゲンを含む食品等の被検試料から、ＳＤＳと２−メルカプトエタノールを用いて抽出した変性及び未変性のアレルゲンの測定サンプルを含む展開液を用い、展開支持体に展開させた後、金コロイドの集積の有無により、アレルゲンを検出するイムノクロマト法において、ウシ胎児血清（ＦＢＳ）が少なくとも１０重量％含まれている展開液を用いる方法であれば特に制限されないが、ウシ胎児血清（ＦＢＳ）が、２０〜１００重量％含まれている展開液を用いることが好ましく、３０〜１００重量％含まれている展開液を用いることがより好ましく、４０〜１００重量％含まれている展開液を用いることが特に好ましく、５０〜１００重量％含まれている展開液を用いることがより一層好ましい。 The method for detecting an allergen by the immunochromatography method of the present invention includes a colloidal gold-labeled antibody in which a colloidal gold antibody is bound to a monoclonal antibody against a denatured and undenatured allergen, and a denatured and undenatured antibody that recognizes a different epitope from the gold colloid-labeled antibody. Includes a development support in which monoclonal antibodies against allergens are fixed at predetermined positions, and measurement samples of denatured and undenatured allergens extracted from test samples such as foods containing allergens using SDS and 2-mercaptoethanol. A method of using a developing solution containing at least 10% by weight of fetal bovine serum (FBS) in an immunochromatographic method for detecting an allergen based on the presence or absence of accumulation of colloidal gold after being developed on a developing support using a developing solution. If there is no particular limitation, fetal bovine serum (FBS) However, it is preferable to use a developing solution containing 20 to 100% by weight, more preferably a developing solution containing 30 to 100% by weight, and a developing solution containing 40 to 100% by weight. It is particularly preferable to use a developing solution containing 50 to 100% by weight.
本発明のイムノクロマト用アレルゲンの検出キットとしては、変性及び未変性のアレルゲンに対するモノクローナル抗体に金コロイドを結合した金コロイド標識抗体を担持させた金コロイド標識抗体担持体、前記金コロイド標識抗体と異なるエピトープを認識する変性及び未変性のアレルゲンに対するモノクローナル抗体が所定の位置に固定された展開支持体と、アレルゲンを含む食品等の被検試料から、変性及び未変性のアレルゲンを抽出するためのＳＤＳと２−メルカプトエタノールを含有する緩衝液と、アレルゲンを含む食品等の被検試料から、ＳＤＳと２−メルカプトエタノールを用いて抽出した変性及び未変性のアレルゲンの測定サンプルを担持させることができるサンプル用担体と、ウシ胎児血清（ＦＢＳ）又はウシ胎児血清（ＦＢＳ）を含む展開液とを備えた検出キットであれば特に制限されないが、上記展開液として、ウシ胎児血清（ＦＢＳ）が少なくとも１０重量％含まれている展開液、好ましくは少なくとも２０重量％含まれている展開液、より好ましくは少なくとも３０重量％含まれている展開液、特に好ましくは少なくとも４０重量％含まれている展開液、より一層好ましくは少なくとも５０重量％、例えば５０〜１００重量％含まれている展開液を備えたものが望ましい。 The immunochromatographic allergen detection kit of the present invention includes a colloidal gold-labeled antibody carrying a colloidal gold antibody bound to a monoclonal antibody against denatured and undenatured allergens, an epitope different from the colloidal gold-labeled antibody. A development support on which monoclonal antibodies against denatured and undenatured allergens recognizing the protein are fixed at predetermined positions, and SDS for extracting denatured and undenatured allergens from a test sample such as food containing allergens and 2 -Sample carrier capable of carrying a measurement sample of denatured and undenatured allergens extracted from a test sample such as a food containing a buffer solution containing mercaptoethanol and allergen using SDS and 2-mercaptoethanol And fetal bovine serum (FBS) or fetal bovine serum ( The detection kit is not particularly limited as long as it includes a developing solution containing BS), but the developing solution contains at least 10% by weight fetal bovine serum (FBS), preferably at least 20% by weight. A developing solution, more preferably at least 30% by weight, particularly preferably at least 40% by weight, even more preferably at least 50% by weight, for example 50-100% by weight. It is desirable to have a developing solution.
上記展開液におけるウシ胎児血清（ＦＢＳ）濃度が１０重量％未満の場合、非特異反応を生じやすく好ましくない。また、展開液には、緩衝液中にウシ胎児血清（ＦＢＳ）の他、必要に応じて界面活性剤、防腐剤、無機塩などの各種添加剤を懸濁もしくは乳濁または溶解せしめて調製することができる。緩衝液は、そのｐＨが４〜１０、特にｐＨ６〜８が好ましく、例えば、リン酸緩衝液（ＰＢＳ）やトリス緩衝液やなどを好適に例示することができる。 When the fetal bovine serum (FBS) concentration in the developing solution is less than 10% by weight, a nonspecific reaction tends to occur, which is not preferable. In addition, the developing solution is prepared by suspending, emulsifying, or dissolving various additives such as surfactant, preservative, and inorganic salt, as necessary, in addition to fetal bovine serum (FBS) in a buffer solution. be able to. The buffer solution preferably has a pH of 4 to 10, particularly preferably 6 to 8, and examples thereof include a phosphate buffer solution (PBS) and a Tris buffer solution.
上記モノクローナル抗体に金コロイドを結合した金コロイド標識抗体の作製方法は従来公知の方法を含め特に制限されないが、例えば、０．２Ｍ炭酸カリウム溶液でｐＨ９．０に調製した金コロイド溶液に、２ｍＭホウ酸緩衝液（ｐＨ９．０）にモノクローナル抗体を溶解した溶液を加え、室温で３０分間反応した後、１０％ＢＳＡ溶液を加え、さらに１５分間反応させ、遠心分離する方法を挙げることができる。また、上記金コロイド標識抗体担持体は、上記作製した金コロイド標識抗体を、例えばガラスウール製コンジュゲートパッドに塗布し、乾燥させることにより作製することができる。 A method for producing a colloidal gold labeled antibody in which colloidal gold is bound to the above monoclonal antibody is not particularly limited, including a conventionally known method. An example is a method in which a solution in which a monoclonal antibody is dissolved in an acid buffer (pH 9.0) is added and reacted at room temperature for 30 minutes, and then a 10% BSA solution is added, further reacted for 15 minutes, and centrifuged. The colloidal gold-labeled antibody carrier can be produced by applying the colloidal gold-labeled antibody produced above onto, for example, a glass wool conjugate pad and drying it.
上記展開支持体は、金コロイド標識抗体と異なるエピトープを認識する変性及び未変性のアレルゲンに対するモノクローナル抗体を含む緩衝液を、例えば、ニトロセルロースメンブレンに直線状に塗布し乾燥させた後、ブロッキング処理することにより作製することができる。 The development support is subjected to a blocking treatment after a buffer solution containing a monoclonal antibody against a modified and unmodified allergen that recognizes an epitope different from that of a colloidal gold-labeled antibody, for example, is linearly applied to a nitrocellulose membrane and dried. Can be produced.
ＳＤＳと２−メルカプトエタノールを用いて変性及び未変性のアレルゲンを抽出して測定サンプルを調製する際に用いられるＳＤＳと２−メルカプトエタノールを含有する緩衝液としては、０．１〜２．０％ＳＤＳ及び０．１〜２．０％２−メルカプトエタノールを含む緩衝液、好ましくは０．５〜１．０％ＳＤＳ及び０．５〜１．０％２−メルカプトエタノールを含む緩衝液を用いると、非特異反応を抑制しうる点で好ましい。 As a buffer solution containing SDS and 2-mercaptoethanol used for preparing a measurement sample by extracting denatured and undenatured allergens using SDS and 2-mercaptoethanol, 0.1 to 2.0% When a buffer containing SDS and 0.1 to 2.0% 2-mercaptoethanol, preferably a buffer containing 0.5 to 1.0% SDS and 0.5 to 1.0% 2-mercaptoethanol is used. It is preferable in that it can suppress non-specific reactions.
上記測定サンプルを担持させることができるサンプル用担体としては、ガラスウール製のサンプルパッドを例示することができる。そして、このサンプル用担体、前記金コロイド標識抗体担持体、前記展開支持体、好ましくはこの展開支持体の他端に展開液の吸収する吸収パッド等の吸収体を順次連結することによりイムノクロマト測定用試験片とすることができる。そして、サンプル用担体に測定サンプルをスポットし、ウシ胎児血清を含む展開液に浸漬すると、測定サンプル中のアレルゲンは毛管現象等により移動し、金コロイド標識抗体と結合し、この抗原抗体複合体は展開支持体上をなおも毛管現象等により移動して、金コロイド標識抗体と異なるエピトープを認識する変性及び未変性のアレルゲンに対するモノクローナル抗体が固定された所定位置で抗原抗体複合体が捕捉されて、所定位置に現れる着色ラインの有無により、アレルゲンを検出することができる。 An example of the sample carrier that can carry the measurement sample is a glass wool sample pad. The sample carrier, the colloidal gold-labeled antibody support, the development support, and preferably the other end of the development support are connected to the other end of the development support, such as an absorbent pad, for immunochromatography. It can be a test piece. Then, when the measurement sample is spotted on a sample carrier and immersed in a developing solution containing fetal bovine serum, the allergen in the measurement sample moves due to capillary action or the like and binds to the colloidal gold labeled antibody, and this antigen-antibody complex is The antigen-antibody complex is captured at a predetermined position where a monoclonal antibody against a modified and native allergen that recognizes an epitope different from the colloidal gold-labeled antibody is still moved by capillary action or the like on the development support, Allergens can be detected by the presence or absence of a colored line appearing at a predetermined position.
上記変性及び未変性のアレルゲンに対するモノクローナル抗体としては、乳アレルゲンの主要成分としてのαｓ１カゼイン、ホエーアレルゲンの主要成分であるβラクトグロブリン、卵白アレルゲンとしてのオボアルブミンとオボムコイド、小麦アレルゲンの主要成分としてのグリアジン、そばの主要タンパク質である分子量２４ｋＤａと７６ｋＤａのタンパク質、落花生の主要タンパク質であるＡｒａｈ１から選ばれる変性及び未変性のアレルゲンを特異的に認識する２種類のモノクローナル抗体を好適に例示することができる。 Monoclonal antibodies against the above-mentioned modified and native allergens include αs1 casein as a major component of milk allergen, β-lactoglobulin as a major component of whey allergen, ovalbumin and ovomucoid as an egg white allergen, as a major component of wheat allergen Two types of monoclonal antibodies specifically recognizing denatured and native allergens selected from gliadin, proteins of buckwheat major proteins of 24 kDa and 76 kDa, and arachi, a major protein of peanuts, can be preferably exemplified. .
より具体的には、本発明者らにより作製された、抗αｓ１カゼインモノクローナル抗体として、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２６３）が産生する抗αｓ１カゼインモノクローナル抗体Ｐａｓ１ＣＮ１や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２６４）が産生する抗αｓ１カゼインモノクローナル抗体Ｐａｓ１ＣＮ２を挙げることができ、抗βラクトグロブリンモノクローナル抗体として、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２８１）が産生する抗βラクトグロブリンモノクローナル抗体ＰβＬＧ１や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２８２）が産生する抗βラクトグロブリンモノクローナル抗体ＰβＬＧ２や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２８３）が産生する抗βラクトグロブリンモノクローナル抗体ＰβＬＧ３を挙げることができる。 More specifically, anti-αs1 casein monoclonal antibody Pas1CN1 produced by hybridoma (FERM-BP-10263) and hybridoma (FERM-BP-10264) are produced as anti-αs1 casein monoclonal antibodies prepared by the present inventors. Anti-αs1 casein monoclonal antibody Pas1CN2 to be produced can be mentioned, and as anti-β-lactoglobulin monoclonal antibody, anti-β-lactoglobulin monoclonal antibody PβLG1 produced by hybridoma (FERM-BP-10281) and hybridoma (FERM-BP-10282) Produced by anti-β-lactoglobulin monoclonal antibody PβLG2 and anti-β-lactoglobulin monoclonal antibody PβLG produced by hybridoma (FERM-BP-10283) It can be mentioned.
また、抗オボアルブミンモノクローナル抗体として、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２６５）が産生する抗オボアルブミンモノクローナル抗体ＰＮＯＡ１や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２６６）が産生する抗オボアルブミンモノクローナル抗体ＰＮＯＡ２や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２７５）が産生する抗オボアルブミンモノクローナル抗体ＰＤＯＡ１や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２７６）が産生する抗オボアルブミンモノクローナル抗体ＰＤＯＡ２を挙げることができ、抗オボムコイドモノクローナル抗体として、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２７９）が産生する抗オボムコイドモノクローナル抗体ＰＮＯＭ１や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２８０）が産生する抗オボムコイドモノクローナル抗体ＰＮＯＭ２や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２７７）が産生する抗オボムコイドモノクローナル抗体ＰＤＯＭ１や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２７８）が産生する抗オボムコイドモノクローナル抗体ＰＤＯＭ２を挙げることができる。 Further, as an anti-ovalbumin monoclonal antibody, an anti-ovalbumin monoclonal antibody PNOA1 produced by a hybridoma (FERM-BP-10265), an anti-ovalbumin monoclonal antibody PNOA2 produced by a hybridoma (FERM-BP-10266), a hybridoma (FERM) Anti-ovalbumin monoclonal antibody PDOA1 produced by (BP-10275) and anti-ovalbumin monoclonal antibody PDOA2 produced by hybridoma (FERM-BP-10276), and hybridoma (FERM-BP) as anti-ovomucoid monoclonal antibody. -10279) produces anti-ovomucoid monoclonal antibody PNOM1 and hybridoma (FERM-BP-10280) And ovomucoid monoclonal antibody PNOM2, hybridoma or (FERM-BP-10277) is an anti-ovomucoid monoclonal antibody produced PDOM1, hybridoma (FERM-BP-10278) can be mentioned anti-ovomucoid monoclonal antibody PDOM2 produced.
また、抗小麦グリアジンモノクローナル抗体として、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２６７）が産生する抗小麦グリアジンモノクローナル抗体ＰＧＬ１や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２６８）が産生する抗小麦グリアジンモノクローナル抗体ＰＧＬ２を挙げることができる。 Examples of the anti-wheat gliadin monoclonal antibody include an anti-wheat gliadin monoclonal antibody PGL1 produced by a hybridoma (FERM-BP-10267) and an anti-wheat gliadin monoclonal antibody PGL2 produced by a hybridoma (FERM-BP-10268). .
また、抗そば粗タンパク質モノクローナル抗体として、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２７２）が産生する抗２４ｋＤａタンパク質モノクローナル抗体ＰＢＷ１や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２７３）が産生する抗７６ｋＤａタンパク質モノクローナル抗体ＰＢＷ２や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２７４）が産生する抗７６ｋＤａタンパク質モノクローナル抗体ＰＢＷ３を挙げることができる。 Further, as anti-soba crude protein monoclonal antibodies, anti-24 kDa protein monoclonal antibody PBW1 produced by hybridoma (FERM-BP-10272), anti-76 kDa protein monoclonal antibody PBW2 produced by hybridoma (FERM-BP-10273), hybridoma ( And anti-76 kDa protein monoclonal antibody PBW3 produced by FERM-BP-10274).
抗落花生Ａｒａ ｈ１タンパク質モノクローナル抗体として、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２６９）が産生する抗未変性Ａｒａｈ１タンパク質モノクローナル抗体ＰＡｈ１−１や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２７０）が産生する抗未変性Ａｒａ ｈ１タンパク質モノクローナル抗体ＰＡｈ１−２や、ハイブリドーマ（ＦＥＲＭ−ＢＰ−１０２７１）が産生する抗加熱変性Ａｒａ ｈ１タンパク質モノクローナル抗体ＰＡｈ１−３を挙げることができる。 As an anti-peanut Ara h1 protein monoclonal antibody, an anti-native Ara h1 protein monoclonal antibody PAh1-1 produced by a hybridoma (FERM-BP-10269) or an anti-native Ara h1 protein monoclonal produced by a hybridoma (FERM-BP-10270) Examples thereof include antibody PAh1-2 and anti-heat-denatured Ara h1 protein monoclonal antibody PAh1-3 produced by a hybridoma (FERM-BP-10271).
以下、実施例により本発明をより具体的に説明するが、本発明の技術的範囲はこれらの例示に限定されるものではない。以下、寄託番号が記載されているモノクローナル抗体（ＭＡｂ）産生ハイブリドーマは、独立行政法人産業技術総合研究所 特許生物寄託センター（住所：茨城県つくば市東１−１−１ つくばセンター中央第６）に受託されている。 EXAMPLES Hereinafter, although an Example demonstrates this invention more concretely, the technical scope of this invention is not limited to these illustrations. Hereinafter, the monoclonal antibody (MAb) -producing hybridoma with the deposit number is entrusted to the National Institute of Advanced Industrial Science and Technology, Patent Biological Deposit Center (Address: 1-1-1 Tsukuba Center, Tsukuba City Center 6th) Has been.
［イムノクロマトグラフィーによるＳＤＳ−２メルカプトエタノール変性オボアルブミンの検出］
１．材料及び方法
（１）金コロイド標識抗体の作製
２ｍＭホウ酸緩衝液（ｐＨ９．０）で１ｍｇ／ｍｌとなるようにＰＤＯＡ２（ＦＥＲＭ−Ｐ−２０６５７）のＭＡｂ溶液を調製した。あらかじめ０．２Ｍ炭酸カリウム溶液でｐＨ９．０に調製した金コロイド溶液（シグマ社製）５ｍｌにＭＡｂ溶液を５００μｌ加え、室温で３０分間反応した後、１０％ＢＳＡ溶液を６３５μｌ加え、さらに１５分間反応させた。遠心分離を行い、１％ＢＳＡ溶液でＯＤ５２５＝１．０になるよう調製した。
[Detection of SDS-2 mercaptoethanol-modified ovalbumin by immunochromatography]
1. Materials and Methods (1) Production of colloidal gold labeled antibody A MAb solution of PDOA2 (FERM-P-20657) was prepared so as to be 1 mg / ml with 2 mM borate buffer (pH 9.0). Add 500 μl of MAb solution to 5 ml of colloidal gold solution (manufactured by Sigma) adjusted to pH 9.0 with 0.2 M potassium carbonate solution in advance, react at room temperature for 30 minutes, add 635 μl of 10% BSA solution, and react for another 15 minutes. I let you. Centrifugation was performed, and a 1% BSA solution was prepared so that OD525 = 1.0.
（２）抗体固定化メンブレンの作製
ＰＢＳで４ｍｇ／ｍｌとなるようにＰＤＯＡ１（ＦＥＲＭ−Ｐ−２０６５６）のＭＡｂ溶液を調製し、ニトロセルロースメンブレンに直線状に塗布し乾燥させた。その後、１％スキムミルクを含むＴＢＳで３７℃、１時間ブロッキング後、ＴＢＳで洗浄し乾燥させた。
(2) Preparation of antibody-immobilized membrane A MAb solution of PDOA1 (FERM-P-20656) was prepared so as to be 4 mg / ml with PBS, and applied linearly to a nitrocellulose membrane and dried. Then, after blocking with TBS containing 1% skimmed milk at 37 ° C. for 1 hour, it was washed with TBS and dried.
（３）イムノクロマトストリップの組立
抗体固定化メンブレンに加えて、被検液スポット用のガラスウール製サンプルパッド、被検液吸収用のガラスウール製吸収パッドを別途用意し、サンプルパッド、抗体固定化メンブレン、吸収パッドの順にそれぞれ貼り付け、イムノクロマトストリップとした。検出用サンプルには、以下のモデル食肉製品を供試した。
(3) Assembling the immunochromatographic strip In addition to the antibody-immobilized membrane, a glass wool sample pad for the test solution spot and a glass wool absorption pad for absorbing the test solution are prepared separately. The absorbent pads were pasted in this order to form an immunochromatographic strip. The following model meat products were used as detection samples.
１）卵タンパク質の調製
穐山ら（特定原材料（卵）測定の厚生労働省通知ＥＬＩＳＡ法の複数機関による評価研究．食品衛生学雑誌，44, 2003, 213-219）に従い、市販鶏卵より卵タンパク質を調製した。
1) Preparation of egg protein According to Hatakeyama et al. (Evaluation research by multiple institutions of the ELISA method for notification of specified raw materials (eggs) by the Ministry of Health, Labor and Welfare. Food hygiene journal, 44, 2003, 213-219), egg protein was prepared from commercial chicken eggs. did.
２）モデル食肉製品
定量試験のためのモデル食品として食肉製品を選択し、表１に示す配合にて各濃度の卵タンパク質を含むモデル食肉製品を作製した。豚赤肉は、豚ロース肉より脂、スジを除去し、５ｍｍで挽肉にしたものを使用した。各配合に従い添加物を計量し、フードプロセッサーにて混合後、塩ビチューブに充填を行った。
2) Model meat product A meat product was selected as a model food for the quantitative test, and a model meat product containing egg protein at each concentration was prepared according to the formulation shown in Table 1. The red pork used was prepared by removing fats and streaks from pork loin and grinding it to 5 mm. Additives were weighed according to each formulation, mixed in a food processor, and filled into a PVC tube.
３）加熱温度・時間
加熱は、７５℃、３０分で行った。
４）サンプルの前処理
加熱後、フードプロセッサーにて均一としたものを検出用サンプルとした。検出用サンプル１ｇを量り取り、それに０．１〜２．０％ＳＤＳ及び０．１〜２．０％２−メルカプトエタノールを含むＰＢＳを１９ｍｌ加え撹拌し、沸騰水中で１時間加熱し、冷却遠心後、上清を測定サンプルとした。
3) Heating temperature and time Heating was performed at 75 ° C. for 30 minutes.
4) Sample pretreatment After heating, the sample that was made uniform by a food processor was used as a sample for detection. Weigh 1 g of sample for detection, add 19 ml of PBS containing 0.1-2.0% SDS and 0.1-2.0% 2-mercaptoethanol, stir, heat in boiling water for 1 hour, and cool and centrifuge Thereafter, the supernatant was used as a measurement sample.
（４）イムノクロマトグラフィーによる非特異反応の確認
調製した金コロイド標識抗体を２０μｌ、展開液として表２に示す各溶液を３０μｌ、卵タンパク質を含まない測定サンプルを５０μｌ加え、イムノクロマトストリップに供試し、非特異反応を確認した。
(4) Confirmation of non-specific reaction by immunochromatography 20 μl of the prepared gold colloid-labeled antibody, 30 μl of each solution shown in Table 2 as a developing solution, and 50 μl of a measurement sample not containing egg protein were added to an immunochromatographic strip. Specific reaction was confirmed.
２．結果
各展開液に対する非特異反応の判定結果を示す。非特異反応が確認されたものを＋、非特異反応がないものを−で表した。
2. Result The determination result of the nonspecific reaction to each developing solution is shown. Those in which a non-specific reaction was confirmed were represented by +, and those having no non-specific reaction were represented by-.
表３〜６に示したように、ＳＤＳ及び２−メルカプトエタノールで抽出したサンプルにおいても非特異反応が確認されなかった展開液は、牛胎児血清（fetal bovine serum：ＦＢＳ）であった。そこで、牛胎児血清（ＦＢＳ）を用いて検出感度の確認を行った。その結果を表７に示す。ＳＤＳが０．５％〜１．０％及び２−メルカプトエタノールが０．５％〜１．０％のとき非特異反応がなく、卵タンパク質を２ｐｐｍまで検出することができた。このことから、ＳＤＳ及び２−メルカプトエタノールを用いた抽出方法を用いた場合でも、展開液に牛胎児血清（ＦＢＳ）を用いることで、変性剤による非特異反応がなく、迅速に検出できるイムノクロマトキットを構築することが可能となった。 As shown in Tables 3 to 6, the developing solution in which a non-specific reaction was not confirmed in the sample extracted with SDS and 2-mercaptoethanol was fetal bovine serum (FBS). Therefore, detection sensitivity was confirmed using fetal bovine serum (FBS). The results are shown in Table 7. When SDS was 0.5% to 1.0% and 2-mercaptoethanol was 0.5% to 1.0%, there was no non-specific reaction, and egg protein could be detected up to 2 ppm. Therefore, even when an extraction method using SDS and 2-mercaptoethanol is used, an immunochromatography kit that can be detected quickly without a non-specific reaction due to a denaturant by using fetal bovine serum (FBS) as a developing solution. It became possible to build.
［イムノクロマトグラフィーによるＳＤＳ−２メルカプトエタノール変性カゼインの検出］
１．材料及び方法
（１）金コロイド標識抗体の作製
２ｍＭホウ酸緩衝液（ｐＨ９．０）で１ｍｇ／ｍｌとなるようにＰαｓ１ＣＮ２（ＦＥＲＭ−ＢＰ−１０２６４）のＭＡｂ溶液を調製した。あらかじめ０．２Ｍ炭酸カリウム溶液でｐＨ９．０に調製した金コロイド溶液（シグマ社製）５ｍｌにＭＡｂ溶液を５００μｌ加え、室温で３０分間反応した後、１０％ＢＳＡ溶液を６３５μｌを加え、さらに１５分間反応させた。遠心分離を行い、１％ＢＳＡ溶液でＯＤ５２５＝１．０になるよう調製した。
[Detection of SDS-2 mercaptoethanol-modified casein by immunochromatography]
1. Materials and Methods (1) Preparation of colloidal gold-labeled antibody A MAb solution of Pαs1CN2 (FERM-BP-10264) was prepared so as to be 1 mg / ml with 2 mM borate buffer (pH 9.0). Add 500 μl of MAb solution to 5 ml of colloidal gold solution (manufactured by Sigma) adjusted to pH 9.0 with 0.2 M potassium carbonate solution in advance, react for 30 minutes at room temperature, add 635 μl of 10% BSA solution, and further for 15 minutes Reacted. Centrifugation was performed, and a 1% BSA solution was prepared so that OD525 = 1.0.
（２）抗体固定化メンブレンの作製
ＰＢＳで４ｍｇ／ｍｌとなるようにＰαｓ１ＣＮ１（ＦＥＲＭ−ＢＰ−１０２６３）のＭＡｂ溶液を調製し、ニトロセルロースメンブレンに直線状に塗布し乾燥させた。その後、０．１％牛皮ゼラチンを含むＴＢＳで３７℃、１時間ブロッキング後、ＴＢＳで洗浄し乾燥させた。
(2) Preparation of antibody-immobilized membrane A MAb solution of Pαs1CN1 (FERM-BP-10263) was prepared so that the concentration was 4 mg / ml with PBS, applied linearly to a nitrocellulose membrane and dried. Then, after blocking with TBS containing 0.1% cowhide gelatin at 37 ° C. for 1 hour, it was washed with TBS and dried.
（３）イムノクロマトストリップの組立
抗体固定化メンブレンに加えて、被検液スポット用のガラスウール製サンプルパッド、被検液吸収用のガラスウール製吸収パッドを別途用意し、サンプルパッド、抗体固定化メンブレン、吸収パッドの順にそれぞれ貼り付け、イムノクロマトストリップとした。乳タンパクは穐山らの方法に従い、ホルスタイン種の新鮮乳より調製した。また、検出用サンプルは表８に示す配合のモデル食肉製品を供試し、加熱温度・時間、サンプルの前処理は前記同様の条件で行った。
(3) Assembling the immunochromatographic strip In addition to the antibody-immobilized membrane, a glass wool sample pad for the test solution spot and a glass wool absorption pad for absorbing the test solution are prepared separately. The absorbent pads were pasted in this order to form an immunochromatographic strip. Milk protein was prepared from fresh Holstein milk according to the method of Hatakeyama et al. In addition, as a sample for detection, a model meat product having the composition shown in Table 8 was tested, and the heating temperature / time and sample pretreatment were performed under the same conditions as described above.
（４）イムノクロマトグラフィーによる非特異反応の確認
調製した金コロイド標識抗体を２０μｌ、展開液として表９に示す各溶液を３０μｌ、乳タンパク質を含まない測定サンプルを５０μｌ加え、イムノクロマトストリップに供試し、非特異反応を確認した。
(4) Confirmation of non-specific reaction by immunochromatography Add 20 μl of the prepared gold colloid-labeled antibody, 30 μl of each solution shown in Table 9 as a developing solution, and 50 μl of a measurement sample not containing milk protein. Specific reaction was confirmed.
２．結果
次に各展開液に対する非特異反応の判定結果を示す。非特異反応が確認されたものを＋、非特異反応がないものを−で表した。
2. Results Next, the determination results of the nonspecific reaction for each developing solution are shown. Those in which a non-specific reaction was confirmed were represented by +, and those having no non-specific reaction were represented by-.
表１０〜１３のように、ＳＤＳ及び２−メルカプトエタノールで抽出したサンプルでも非特異反応が確認されなかった展開液は、牛胎児血清であった。そこで、牛胎児血清（ＦＢＳ）を用いて検出感度の確認を行った。その結果、表１４のようにＳＤＳが０．５％〜１．０％及び２−メルカプトエタノールが０．５％〜１．０％のときに非特異反応がなく、乳タンパク質を２ｐｐｍまで検出することができた。このことから、ＳＤＳ及び２−メルカプトエタノールを用いた抽出方法を用いた場合でも、展開液に牛胎児血清（ＦＢＳ）を用いることで、変性剤による非特異反応がなく、迅速に検出できるイムノクロマトキットを構築することが可能となった。 As shown in Tables 10 to 13, the developing solution in which a nonspecific reaction was not confirmed even in the sample extracted with SDS and 2-mercaptoethanol was fetal bovine serum. Therefore, detection sensitivity was confirmed using fetal bovine serum (FBS). As a result, as shown in Table 14, there was no non-specific reaction when SDS was 0.5% to 1.0% and 2-mercaptoethanol was 0.5% to 1.0%, and milk protein was detected up to 2 ppm. I was able to. Therefore, even when an extraction method using SDS and 2-mercaptoethanol is used, an immunochromatography kit that can be detected quickly without a non-specific reaction due to a denaturant by using fetal bovine serum (FBS) as a developing solution. It became possible to build.
［イムノクロマトグラフィーによるＳＤＳ−２メルカプトエタノール変性小麦タンパク質の検出］
１．材料及び方法
（１）金コロイド標識抗体の作製
２ｍＭホウ酸緩衝液（ｐＨ９．０）で１ｍｇ／ｍｌとなるようにＰＧＬ２（ＦＥＲＭ−ＢＰ−１０２６８）のＭＡｂ溶液を調製した。あらかじめ０．２Ｍ炭酸カリウム溶液でｐＨ９．０に調製した金コロイド溶液（シグマ社製）５ｍｌにＭＡｂ溶液を５００μｌ加え、室温で３０分間反応した後、１０％ＢＳＡ溶液を６３５μｌを加え、さらに１５分間反応させた。遠心分離を行い、１％ＢＳＡ溶液でＯＤ５２５＝１．０になるよう調製した。
[Detection of SDS-2 mercaptoethanol-denatured wheat protein by immunochromatography]
1. Materials and Methods (1) Preparation of colloidal gold-labeled antibody A MAb solution of PGL2 (FERM-BP-10268) was prepared so as to be 1 mg / ml with 2 mM borate buffer (pH 9.0). Add 500 μl of MAb solution to 5 ml of colloidal gold solution (manufactured by Sigma) adjusted to pH 9.0 with 0.2 M potassium carbonate solution in advance, react for 30 minutes at room temperature, add 635 μl of 10% BSA solution, and further for 15 minutes Reacted. Centrifugation was performed, and a 1% BSA solution was prepared so that OD525 = 1.0.
（２）抗体固定化メンブレンの作製
ＰＢＳで４ｍｇ／ｍｌとなるようにＰＧＬ１（ＦＥＲＭ−ＢＰ−１０２６７）のＭＡｂ溶液を調製し、ニトロセルロースメンブレンに直線状に塗布し乾燥させた。その後、１．０％牛皮ゼラチンを含むＴＢＳで３７℃、１時間ブロッキング後、ＴＢＳで洗浄し乾燥させた。
(2) Preparation of antibody-immobilized membrane A MAb solution of PGL1 (FERM-BP-10267) was prepared to 4 mg / ml with PBS, applied linearly to a nitrocellulose membrane and dried. Then, after blocking with TBS containing 1.0% cowhide gelatin at 37 ° C. for 1 hour, it was washed with TBS and dried.
（３）イムノクロマトストリップの組立
抗体固定化メンブレンに加えて、被検液スポット用のガラスウール製サンプルパッド、被検液吸収用のガラスウール製吸収パッドを別途用意し、サンプルパッド、抗体固定化メンブレン、吸収パッドの順にそれぞれ貼り付け、イムノクロマトストリップとした。卵タンパク質は、穐山らの方法に従い、市販小麦粉末より調整した。また、検出用サンプルは、表１５に示す配合のモデル食肉製品を供試し、加熱温度・時間、サンプルの前処理は前記同様の条件で行った。各配合に従い添加物を計量し、フードプロセッサーにて混合後、塩ビチューブに充填を行った。
(3) Assembling the immunochromatographic strip In addition to the antibody-immobilized membrane, a glass wool sample pad for the test solution spot and a glass wool absorption pad for absorbing the test solution are prepared separately. The absorbent pads were pasted in this order to form an immunochromatographic strip. Egg protein was prepared from commercially available wheat powder according to the method of Hiyama et al. Further, as the detection sample, a model meat product having the composition shown in Table 15 was tested, and the heating temperature / time and sample pretreatment were performed under the same conditions as described above. Additives were weighed according to each formulation, mixed in a food processor, and filled into a PVC tube.
（４）イムノクロマトグラフィーによる非特異反応の確認
調製した金コロイド標識抗体を２０μｌ、展開液として表１６に示す各溶液を３０μｌ、小麦タンパク質を含まない測定サンプルを５０μｌ加え、イムノクロマトストリップに供試し、非特異反応を確認した。
(4) Confirmation of non-specific reaction by immunochromatography 20 μl of the prepared gold colloid-labeled antibody, 30 μl of each solution shown in Table 16 as a developing solution, and 50 μl of a measurement sample not containing wheat protein were added to an immunochromatographic strip. Specific reaction was confirmed.
２．結果
次に各展開液に対する非特異反応の判定結果を示す。非特異反応が確認されたものを＋、非特異反応がないものを−で表した。
2. Results Next, the determination results of the nonspecific reaction for each developing solution are shown. Those in which a non-specific reaction was confirmed were represented by +, and those having no non-specific reaction were represented by-.
表１７〜２０のように、ＳＤＳ及び２−メルカプトエタノールで抽出したサンプルでも非特異反応が確認されなかった展開液は、牛胎児血清であった。そこで、牛胎児血清（ＦＢＳ）を用いて検出感度の確認を行った。その結果、表２１のようにＳＤＳが０．５％〜１．０％及び２−メルカプトエタノールが０．５％〜１．０％のときに非特異反応がなく、小麦タンパク質を２ｐｐｍまで検出することができた。このことから、ＳＤＳ及び２−メルカプトエタノールを用いた抽出方法を用いた場合でも、展開液に牛胎児血清（ＦＢＳ）を用いることで、変性剤による非特異反応がなく、迅速に検出できるイムノクロマトキットを構築することが可能となった。 As shown in Tables 17 to 20, the developing solution in which the nonspecific reaction was not confirmed even in the sample extracted with SDS and 2-mercaptoethanol was fetal bovine serum. Therefore, detection sensitivity was confirmed using fetal bovine serum (FBS). As a result, as shown in Table 21, when SDS is 0.5% to 1.0% and 2-mercaptoethanol is 0.5% to 1.0%, there is no non-specific reaction and wheat protein is detected up to 2 ppm. I was able to. Therefore, even when an extraction method using SDS and 2-mercaptoethanol is used, an immunochromatography kit that can be detected quickly without a non-specific reaction due to a denaturant by using fetal bovine serum (FBS) as a developing solution. It became possible to build.
［イムノクロマトグラフィーによるＳＤＳ−２メルカプトエタノール変性そばタンパク質の検出］
１．材料及び方法
（１）金コロイド標識抗体の作製
２ｍＭホウ酸緩衝液（ｐＨ９．０）で１ｍｇ／ｍｌとなるようにＰＢＷ２（ＦＥＲＭ−ＢＰ−１０２７４）のＭＡｂ溶液を調製した。あらかじめ０．２Ｍ炭酸カリウム溶液でｐＨ９．０に調製した金コロイド溶液（シグマ社製）５ｍｌにＭＡｂ溶液を５００μｌ加え、室温で３０分間反応した後、１０％ＢＳＡ溶液を６３５μｌ加え、さらに１５分間反応させた。遠心分離を行い、１％ＢＳＡ溶液でＯＤ５２５＝１．０になるよう調製した。
[Detection of SDS-2 mercaptoethanol-denatured buckwheat protein by immunochromatography]
1. MATERIALS AND METHOD (1) Preparation of colloidal gold labeled antibody A MAb solution of PBW2 (FERM-BP-10274) was prepared so as to be 1 mg / ml with 2 mM borate buffer (pH 9.0). Add 500 μl of MAb solution to 5 ml of colloidal gold solution (manufactured by Sigma) adjusted to pH 9.0 with 0.2 M potassium carbonate solution in advance, react at room temperature for 30 minutes, add 635 μl of 10% BSA solution, and react for another 15 minutes. I let you. Centrifugation was performed, and a 1% BSA solution was prepared so that OD525 = 1.0.
（２）抗体固定化メンブレンの作製
ＰＢＳで４ｍｇ／ｍｌとなるようにＰＢＷ１（ＦＥＲＭ−ＢＰ−１０２７２）とＰＢＷ２（ＦＥＲＭ−ＢＰ−１０２７３）のＭＡｂ溶液を調製し、ニトロセルロースメンブレンに直線状に塗布し乾燥させた。その後、１％スキムミルクを含むＴＢＳで３７℃、１時間ブロッキング後、ＴＢＳで洗浄し乾燥させた。
(2) Preparation of antibody-immobilized membrane A MAb solution of PBW1 (FERM-BP-10272) and PBW2 (FERM-BP-10273) was prepared to 4 mg / ml in PBS, and applied linearly to the nitrocellulose membrane. And dried. Then, after blocking with TBS containing 1% skimmed milk at 37 ° C. for 1 hour, it was washed with TBS and dried.
（３）イムノクロマトストリップの組立
抗体固定化メンブレンに加えて、被検液スポット用のガラスウール製サンプルパッド、被検液吸収用のガラスウール製吸収パッドを別途用意し、サンプルパッド、抗体固定化メンブレン、吸収パッドの順にそれぞれ貼り付け、イムノクロマトストリップとした。そばタンパク質は、穐山らの方法に従い、市販そば粉末より調整した。また、検出用サンプルは、表２２に示す配合のモデル食肉製品を供試し、加熱温度・時間、サンプルの前処理は前記同様の条件で行った。各配合に従い添加物を計量し、フードプロセッサーにて混合後、塩ビチューブに充填を行った。
(3) Assembling the immunochromatographic strip In addition to the antibody-immobilized membrane, a glass wool sample pad for the test solution spot and a glass wool absorption pad for absorbing the test solution are prepared separately. The absorbent pads were pasted in this order to form an immunochromatographic strip. Buckwheat protein was prepared from commercially available buckwheat powder according to the method of Hiyama et al. The sample for detection was a model meat product having the composition shown in Table 22, and the heating temperature / time and sample pretreatment were performed under the same conditions as described above. Additives were weighed according to each formulation, mixed in a food processor, and filled into a PVC tube.
（４）イムノクロマトグラフィーによる非特異反応の確認
調製した金コロイド標識抗体を２０μｌ、展開液として表２３に示す各溶液を３０μｌ、そばタンパク質を含まない測定サンプルを５０μｌ加え、イムノクロマトストリップに供試し、非特異反応を確認した。
(4) Confirmation of non-specific reaction by immunochromatography Add 20 μl of the prepared gold colloid-labeled antibody, 30 μl of each solution shown in Table 23 as a developing solution, and 50 μl of a measurement sample not containing buckwheat protein. Specific reaction was confirmed.
２．結果
次に各展開液に対する非特異反応の判定結果を示す。非特異反応が確認されたものを＋、非特異反応がないものを−で表した。
2. Results Next, the determination results of the nonspecific reaction for each developing solution are shown. Those in which a non-specific reaction was confirmed were represented by +, and those having no non-specific reaction were represented by-.
表２４〜２７のように、ＳＤＳ及び２−メルカプトエタノールで抽出したサンプルでも非特異反応が確認されなかった展開液は、牛胎児血清であった。そこで、牛胎児血清（ＦＢＳ）を用いて検出感度の確認を行った。その結果、表２８のようにＳＤＳが０．５％〜１．０％及び２−メルカプトエタノールが０．５％〜１．０％のときに非特異反応がなく、そばタンパク質を２ｐｐｍまで検出することができた。このことから、ＳＤＳ及び２−メルカプトエタノールを用いた抽出方法を用いた場合でも、展開液に牛胎児血清（ＦＢＳ）を用いることで、変性剤による非特異反応がなく、迅速に検出できるイムノクロマトキットを構築することが可能となった。 As shown in Tables 24-27, the developing solution in which a non-specific reaction was not confirmed even in the sample extracted with SDS and 2-mercaptoethanol was fetal bovine serum. Therefore, detection sensitivity was confirmed using fetal bovine serum (FBS). As a result, as shown in Table 28, when SDS is 0.5% to 1.0% and 2-mercaptoethanol is 0.5% to 1.0%, there is no non-specific reaction and buckwheat protein is detected up to 2 ppm. I was able to. Therefore, even when an extraction method using SDS and 2-mercaptoethanol is used, an immunochromatography kit that can be detected quickly without a non-specific reaction due to a denaturant by using fetal bovine serum (FBS) as a developing solution. It became possible to build.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006103678A JP4690928B2 (en) | 2006-04-04 | 2006-04-04 | Allergen detection method by immunochromatography |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006103678A JP4690928B2 (en) | 2006-04-04 | 2006-04-04 | Allergen detection method by immunochromatography |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007278773A JP2007278773A (en) | 2007-10-25 |
| JP4690928B2 true JP4690928B2 (en) | 2011-06-01 |
Family
ID=38680368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006103678A Active JP4690928B2 (en) | 2006-04-04 | 2006-04-04 | Allergen detection method by immunochromatography |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4690928B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103674657A (en) * | 2013-12-24 | 2014-03-26 | 山东莱博生物科技有限公司 | Kit for processing antigen-antibody immune complex in serum or plasma sample and application of kit |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5133663B2 (en) * | 2007-11-30 | 2013-01-30 | 森永製菓株式会社 | Food component extraction method, food inspection method, and food inspection kit |
| JP5310154B2 (en) * | 2008-03-18 | 2013-10-09 | 日立化成株式会社 | Method for producing chromatographic strips |
| JP5735411B2 (en) * | 2009-02-23 | 2015-06-17 | プリマハム株式会社 | Allergen detection method by immunochromatography |
| JP5451854B2 (en) * | 2012-10-30 | 2014-03-26 | 森永製菓株式会社 | Food component extraction method, food inspection method, and food inspection kit |
| CN103439502B (en) * | 2013-06-28 | 2015-12-23 | 北京新华联协和药业有限责任公司 | A kind of rapid specific antibody IgE detection kit and preparation method thereof |
| JP6712863B2 (en) * | 2016-01-19 | 2020-06-24 | プリマハム株式会社 | Method for detecting allergen by immunochromatography |
| JP2022076838A (en) | 2020-11-10 | 2022-05-20 | プリマハム株式会社 | Allergen detection kit |
| CN112526142A (en) * | 2020-11-25 | 2021-03-19 | 杭州福德敏生物技术有限公司 | Egg immunofluorescence detection test strip and application and detection method thereof |
| CN115575639A (en) * | 2022-10-09 | 2023-01-06 | 中国海洋大学 | Method for simultaneously detecting multiple food allergens by using quantum dot fluorescent probe |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000065820A (en) * | 1998-08-19 | 2000-03-03 | Allergen Free Technology Kenkyusho:Kk | Aqueous solution and method for protein extraction, and method for analyzing allergen |
| JP2001305134A (en) * | 2000-04-21 | 2001-10-31 | Shinto Fine Co Ltd | Simple inspection kit for mite allergen and method for detecting mite allergen using it |
| JP2002267670A (en) * | 2001-03-07 | 2002-09-18 | Asahi Beer Yakuhin Kk | Method of analyzing specimen by using specific bond |
| JP2004085425A (en) * | 2002-08-28 | 2004-03-18 | Morinaga Milk Ind Co Ltd | Detection reagent and detection method of material |
| JP2005106811A (en) * | 2004-08-13 | 2005-04-21 | Morinaga & Co Ltd | Immunoassay |
| JP2006071509A (en) * | 2004-09-02 | 2006-03-16 | Nippon Meat Packers Inc | Food component extracting liquid |
-
2006
- 2006-04-04 JP JP2006103678A patent/JP4690928B2/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000065820A (en) * | 1998-08-19 | 2000-03-03 | Allergen Free Technology Kenkyusho:Kk | Aqueous solution and method for protein extraction, and method for analyzing allergen |
| JP2001305134A (en) * | 2000-04-21 | 2001-10-31 | Shinto Fine Co Ltd | Simple inspection kit for mite allergen and method for detecting mite allergen using it |
| JP2002267670A (en) * | 2001-03-07 | 2002-09-18 | Asahi Beer Yakuhin Kk | Method of analyzing specimen by using specific bond |
| JP2004085425A (en) * | 2002-08-28 | 2004-03-18 | Morinaga Milk Ind Co Ltd | Detection reagent and detection method of material |
| JP2005106811A (en) * | 2004-08-13 | 2005-04-21 | Morinaga & Co Ltd | Immunoassay |
| JP2006071509A (en) * | 2004-09-02 | 2006-03-16 | Nippon Meat Packers Inc | Food component extracting liquid |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103674657A (en) * | 2013-12-24 | 2014-03-26 | 山东莱博生物科技有限公司 | Kit for processing antigen-antibody immune complex in serum or plasma sample and application of kit |
| CN103674657B (en) * | 2013-12-24 | 2014-08-20 | 朱之炜 | Kit for processing antigen-antibody immune complex in serum or plasma sample and application of kit |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007278773A (en) | 2007-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5735411B2 (en) | Allergen detection method by immunochromatography | |
| JP4690928B2 (en) | Allergen detection method by immunochromatography | |
| US8361460B2 (en) | Food allergens, method of detecting food allergens and method of detecting food allergy-inducing foods | |
| JP5043077B2 (en) | Method for detecting peanut allergen | |
| JP2009271091A5 (en) | ||
| JP6510307B2 (en) | Method of detecting allergen by immunochromatography | |
| JP6712863B2 (en) | Method for detecting allergen by immunochromatography | |
| JP6778086B2 (en) | How to detect allergens in chocolate samples | |
| JP4958369B2 (en) | Food allergen, method for detecting food allergen and method for detecting food allergy-inducing food | |
| JP2020020759A (en) | Method for detecting allergen by immuno-chromatography and kit therefor | |
| JP6778083B2 (en) | How to detect wheat allergens in chocolate samples | |
| Ribes-Koninckx et al. | Value and Use of Serologic Markers of Celiac Disease | |
| EP1861705B1 (en) | Method for determining an allergic response | |
| WO2023190098A1 (en) | Examination kit and examination method for peanut allergen | |
| JP2003294748A (en) | Antibody for egg component inspection, method of inspection, and kit for inspection | |
| TWI342784B (en) | A mixture of food allergens and a method for preparing the same | |
| AU2009251002B2 (en) | Food allergens, method of detecting food allergens and method of detecting food allergy-inducing foods | |
| JP2008298664A (en) | Food inspection method and food inspection kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090210 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110119 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110124 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110218 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4690928 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140225 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |